title: Hepatitis G virus exposure in dialysis patients.
abstract: BACKGROUND
  Hepatitis G virus (HGV) is a blood-borne virus. The predominant route of its transmission is parenteral. The aim of this study was to assess the frequency of HGV exposure in haemodialysis (HD) and continuous ambulatory peritoneal dialysis (CAPD) patients in Iran.
  
  
  METHODS
  This study was performed in a major dialysis centre in Tehran, Iran. The study cohort consisted of 77 patients on HD and 13 patients on CAPD. The presence of anti-HGV envelope protein E2 (anti-E2) in the blood serum, as determined by means of an ELISA assay, indicated HGV exposure. All patients were also screened for hepatitis B surface antigen (HBsAg), hepatitis B surface antibody (anti-HBs) and hepatitis C antibody (anti-HCV). In patients who tested positive for anti-E2, HGV RNA was detected by RT-PCR using primers derived from the NS5A region of the viral genome.
  
  
  RESULTS
  In total, 3.89% of the HD patients and none of the CAPD patients tested positive for anti-E2. None of the patients tested positive for HGV RNA. The mean age of the anti-E2-positive patients was 53.3 +/- 26.5 years, with 66.66% having previously received blood transfusion. The mean duration of dialysis of the anti-E2-positive patients was 68 +/- 64 months. Co-infection with HCV or HBV was not observed in the anti-E2 positive patients.
  
  
  CONCLUSIONS
  The rate of exposure to HGV was low among the dialysis patients in our study. The appearance of anti-E2 was accompanied by clearance of serum HGV-RNA. No relationship was noted between HGV exposure and age, sex, history of blood transfusion, time on dialysis and HCV or HBV markers.
authors.affiliation: Clinical Research Department, Pasteur Institute of Iran, No 69, Pasteur Ave., Tehran, 13164, Iran.
authors.forename: Ali
authors.initials: A
authors.lastname: Eslamifar
authors.forename: Rasool
authors.initials: R
authors.lastname: Hamkar
authors.forename: Amitis
authors.initials: A
authors.lastname: Ramezani
authors.forename: Farrokhlagha
authors.initials: F
authors.lastname: Ahmadi
authors.forename: Latif
authors.initials: L
authors.lastname: Gachkar
authors.forename: Somayeh
authors.initials: S
authors.lastname: Jalilvand
authors.forename: Ladan
authors.initials: L
authors.lastname: Adibi
authors.forename: Shahnaz
authors.initials: S
authors.lastname: Atabak
authors.forename: Ali
authors.initials: A
authors.lastname: Khameneh
authors.forename: Ramin
authors.initials: R
authors.lastname: Ghadimi
authors.forename: Arezoo
authors.initials: A
authors.lastname: Aghakhani
mesh_terms: D016009:Chi-Square Distribution; D003430:Cross-Sectional Studies; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D018178:Flaviviridae Infections / Q000453:epidemiology*; D029407:GB virus C / Q000302:isolation & purification*; D006525:Hepatitis, Viral, Human / Q000453:epidemiology*; D006801:Humans; D007492:Iran / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D010531:Peritoneal Dialysis, Continuous Ambulatory; D006435:Renal Dialysis; D020133:Reverse Transcriptase Polymerase Chain Reaction